GEORGE F TIDMARSH
CIK 1287235 · President, CEO & Secretary · last filed 2025-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2
Companies
4
Total Filings
54
Lifetime Open-Market Net
$961.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| REVBW | Director | 268 | $0.01 | $2 | $389.1K | 12 | 2025-02-13 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 77,331 | $1.12 | $86.6K | $0 | 3 | 2019-09-23 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | President, CEO & Secretary | 1,285,895 | $6.22 | $8.00M | $552.2K | 35 | 2019-04-17 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | CSO and Head of R&D Operations | 40,000 | $1.03 | $41.2K | $20.1K | 3 | 2011-01-03 |
Recent Filings · Page 3 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +874 | $5.0K | EDGAR |
| 2019-01-09 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +2,000 | $11.7K | EDGAR |
| 2019-01-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +154 | $1.2K | EDGAR |
| 2019-01-03 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +112 | $1.2K | EDGAR |
| 2018-12-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +100 | $1.2K | EDGAR |
| 2018-11-19 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +97 | $1.2K | EDGAR |
| 2018-11-01 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +89 | $1.2K | EDGAR |
| 2018-10-15 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +88 | $1.2K | EDGAR |
| 2018-01-04 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.